Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s13311-016-0450-6.

Title:
Exosomes in Viral Disease | Neurotherapeutics
Description:
Viruses have evolved many mechanisms by which to evade and subvert the immune system to ensure survival and persistence. However, for each method undertaken by the immune system for pathogen removal, there is a counteracting mechanism utilized by pathogens. The new and emerging role of microvesicles in immune intercellular communication and function is no different. Viruses across many different families have evolved to insert viral components in exosomes, a subtype of microvesicle, with many varying downstream effects. When assessed cumulatively, viral antigens in exosomes increase persistence through cloaking viral genomes, decoying the immune system, and even by increasing viral infection in uninfected cells. Exosomes therefore represent a source of viral antigen that can be used as a biomarker for disease and targeted for therapy in the control and eradication of these disorders. With the rise in the persistence of new and reemerging viruses like Ebola and Zika, exploring the role of exosomes become more important than ever.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Social Networks

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

pubmed, exosomes, article, google, scholar, cas, cells, viral, virus, central, cell, infection, hiv, viruses, human, immune, exosome, vesicles, proteins, exosomal, pathway, extracellular, tax, role, shown, membrane, biol, protein, system, infected, virol, disease, dendritic, release, found, mechanism, important, type, endosomal, escrt, rab, particles, raba, zika, cellular, plasma, htlv, ebv, communication, shed,

Topics {✒️}

gov/zika/hc-providers/qa-pregnant-women myelopathy/tropical spastic paraparesis epstein-barr virus-infected cells gov/ct2/show/nct02147418 adult t-cell leukemia trigger guillain-barre syndrome cd4+ t-cell depletion lymphotropic virus type homogenous cup-shaped appearance viral oncogenes e6/e7 van der sluijs extracellular vesicle uptake epstein-barr virus latency tcr/cd3/zeta complex long-term infection favor tetraspanin-enriched microdomains reveals autophagy/multivesicular body pathways van eijndhoven ma central nervous system directing ubiquitin-labeled proteins t-cell immunoglobulin cytomegalovirus-mediated cis-infection increase t-cell apoptosis related subjects direct cell–cell contact target cell trans-infection campbell pe human leukocyte antigen-dr ebv-negative skin lesions efficient receptor-independent uptake hsv1-infected cells express hhv-6b-infected cells dendritic cell-derived exosomes hpv-positive tumor cells respiratory syncytial virus sampey gc b-cell exosome proteins epstein–barr virus epstein-barr virus capture mhc-peptide complexes v-snare proteins involved human papilloma virus de castro ro ali sa privacy choices/manage cookies herpes virus transcription t-cell activation including nasopharyngeal sarcomas fraile-ramos human herpes virus

Questions {❓}

  • Exosomes: cell garbage can, therapeutic carrier, or trojan horse?
  • HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?
  • Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons?
  • Thus, the question becomes: Does their ability to manipulate exosomal contents allow these viruses to establish latency, or does long-term infection favor the ability to isolate exosomes while transient infections have been largely ignored due to the belief that immune clearance negates the risk of exosomes?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Exosomes in Viral Disease
         description:Viruses have evolved many mechanisms by which to evade and subvert the immune system to ensure survival and persistence. However, for each method undertaken by the immune system for pathogen removal, there is a counteracting mechanism utilized by pathogens. The new and emerging role of microvesicles in immune intercellular communication and function is no different. Viruses across many different families have evolved to insert viral components in exosomes, a subtype of microvesicle, with many varying downstream effects. When assessed cumulatively, viral antigens in exosomes increase persistence through cloaking viral genomes, decoying the immune system, and even by increasing viral infection in uninfected cells. Exosomes therefore represent a source of viral antigen that can be used as a biomarker for disease and targeted for therapy in the control and eradication of these disorders. With the rise in the persistence of new and reemerging viruses like Ebola and Zika, exploring the role of exosomes become more important than ever.
         datePublished:2016-06-20T00:00:00Z
         dateModified:2016-06-20T00:00:00Z
         pageStart:535
         pageEnd:546
         sameAs:https://doi.org/10.1007/s13311-016-0450-6
         keywords:
            Exosomes
            microvesicles
            multivesicular bodies
            “back fusion”
            ESCRT
            Neurosciences
            Neurology
            Neurosurgery
            Neurobiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13311-016-0450-6/MediaObjects/13311_2016_450_Fig1_HTML.gif
         isPartOf:
            name:Neurotherapeutics
            issn:
               1878-7479
               1933-7213
            volumeNumber:13
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Monique R. Anderson
               affiliation:
                     name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section
                     address:
                        name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Virginia School of Medicine
                     address:
                        name:Department of Pathology Molecular and Cellular Basis of Disease Graduate Program, University of Virginia School of Medicine, Charlottesville, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Fatah Kashanchi
               affiliation:
                     name:George Mason University, National Center for Biodefense and Infectious Disease, Laboratory of Molecular Virology
                     address:
                        name:George Mason University, National Center for Biodefense and Infectious Disease, Laboratory of Molecular Virology, Manassas, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Steven Jacobson
               affiliation:
                     name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section
                     address:
                        name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Exosomes in Viral Disease
      description:Viruses have evolved many mechanisms by which to evade and subvert the immune system to ensure survival and persistence. However, for each method undertaken by the immune system for pathogen removal, there is a counteracting mechanism utilized by pathogens. The new and emerging role of microvesicles in immune intercellular communication and function is no different. Viruses across many different families have evolved to insert viral components in exosomes, a subtype of microvesicle, with many varying downstream effects. When assessed cumulatively, viral antigens in exosomes increase persistence through cloaking viral genomes, decoying the immune system, and even by increasing viral infection in uninfected cells. Exosomes therefore represent a source of viral antigen that can be used as a biomarker for disease and targeted for therapy in the control and eradication of these disorders. With the rise in the persistence of new and reemerging viruses like Ebola and Zika, exploring the role of exosomes become more important than ever.
      datePublished:2016-06-20T00:00:00Z
      dateModified:2016-06-20T00:00:00Z
      pageStart:535
      pageEnd:546
      sameAs:https://doi.org/10.1007/s13311-016-0450-6
      keywords:
         Exosomes
         microvesicles
         multivesicular bodies
         “back fusion”
         ESCRT
         Neurosciences
         Neurology
         Neurosurgery
         Neurobiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13311-016-0450-6/MediaObjects/13311_2016_450_Fig1_HTML.gif
      isPartOf:
         name:Neurotherapeutics
         issn:
            1878-7479
            1933-7213
         volumeNumber:13
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Monique R. Anderson
            affiliation:
                  name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section
                  address:
                     name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Virginia School of Medicine
                  address:
                     name:Department of Pathology Molecular and Cellular Basis of Disease Graduate Program, University of Virginia School of Medicine, Charlottesville, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Fatah Kashanchi
            affiliation:
                  name:George Mason University, National Center for Biodefense and Infectious Disease, Laboratory of Molecular Virology
                  address:
                     name:George Mason University, National Center for Biodefense and Infectious Disease, Laboratory of Molecular Virology, Manassas, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Steven Jacobson
            affiliation:
                  name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section
                  address:
                     name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Neurotherapeutics
      issn:
         1878-7479
         1933-7213
      volumeNumber:13
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section
      address:
         name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA
         type:PostalAddress
      name:University of Virginia School of Medicine
      address:
         name:Department of Pathology Molecular and Cellular Basis of Disease Graduate Program, University of Virginia School of Medicine, Charlottesville, USA
         type:PostalAddress
      name:George Mason University, National Center for Biodefense and Infectious Disease, Laboratory of Molecular Virology
      address:
         name:George Mason University, National Center for Biodefense and Infectious Disease, Laboratory of Molecular Virology, Manassas, USA
         type:PostalAddress
      name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section
      address:
         name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Monique R. Anderson
      affiliation:
            name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section
            address:
               name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA
               type:PostalAddress
            type:Organization
            name:University of Virginia School of Medicine
            address:
               name:Department of Pathology Molecular and Cellular Basis of Disease Graduate Program, University of Virginia School of Medicine, Charlottesville, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Fatah Kashanchi
      affiliation:
            name:George Mason University, National Center for Biodefense and Infectious Disease, Laboratory of Molecular Virology
            address:
               name:George Mason University, National Center for Biodefense and Infectious Disease, Laboratory of Molecular Virology, Manassas, USA
               type:PostalAddress
            type:Organization
      name:Steven Jacobson
      affiliation:
            name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section
            address:
               name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA
      name:Department of Pathology Molecular and Cellular Basis of Disease Graduate Program, University of Virginia School of Medicine, Charlottesville, USA
      name:George Mason University, National Center for Biodefense and Infectious Disease, Laboratory of Molecular Virology, Manassas, USA
      name:National Institutes of Health, National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, Viral Immunology Section, Bethesda, USA

External Links {🔗}(521)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.78s.